Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 199 clinical trials
Featured trial
Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Open-label, BID application to all affected areas identified at BSLN for 4 weeks (maximum use trial (MUsT) period). The next 4 weeks (treatment extension period) will be applied BID to active lesions only for the next 4 weeks for a total treatment period of 8 weeks. Eligible participants will be …

  • 0 views
  • 21 Mar, 2022
  • 16 locations
Featured trial
Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia

Background: Severe aplastic anemia is a rare and serious blood disorder. It happens when the immune system starts to attack the bone marrow cells. This causes the bone marrow to stop making red blood cells, platelets, and white blood cells. Standard treatment for this disease is horse-ATG and cyclosporine, which …

aplastic anemia
anemia
myelodysplastic syndromes
myelodysplastic syndrome (mds)
anemia studies
  • 172 views
  • 22 Dec, 2020
  • 1 location
Genetic Testing for Common Disorders: Learning from the Experiences of Individuals who were Tested to Determine their Genetic Risk for Alzheimer’s Disease

genetic testing for Alzheimer’s disease risk. If you are concerned about Alzheimer’s disease or memory changes in yourself or a loved one, the Alzheimer’s Association encourages you to have a frank

Accepts healthy volunteers
Online studies
  • 1471 views
  • 23 Sep, 2022
  • 1 location
  • Online study
AN INTERVENTIONAL PHASE 2, OPEN-LABEL, ONE-ARM, MULTI-CENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06835375 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE PRIMARY IMMUNE THROMBOCYTOPENIA

This is a Phase 2, open-label, single arm, multicenter, multiple subcutaneous injection, safety and efficacy study of PF-06835375 in adult participants with primary immune thrombocytopenia (ITP

  • 0 views
  • 24 Oct, 2022
  • 8 locations
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Primary immune thrombocytopenia (ITP) is a rare disease that results in low levels of platelets - the cells that help blood clot. The main aim of the study is to check for side effects

  • 3 views
  • 07 Oct, 2022
  • 8 locations
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children

To compare the efficacy of two different dosage regimens of intravenous immune globulin (IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia, and to reduce related

  • 0 views
  • 07 Oct, 2022
  • 1 location
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia (ADVANCE SC+)

A Phase 3 study to evaluate the safety and efficacy of efgartigimod PH20 subcutaneous in adult patients with primary immune thrombocytopenia

  • 0 views
  • 14 Jul, 2022
  • 37 locations
  • 36 views
  • 24 Oct, 2022
  • 125 locations
Inhaled Heparin for Hospitalised COVID-19 Patients (INHALE-HEP)

This meta-trial is a prospective collaborative individual participant data meta-analysis of randomised controlled trials and early phase studies. Individual studies will be conducted in multiple countries, including Australia, the UK, the USA, Ireland, Argentina, Brazil and Egypt. Adult patients admitted to the hospital with confirmed SARS-CoV-2 infection, who do not …

  • 5 views
  • 25 Mar, 2022
  • 2 locations
Anti-BCMA CAR T-Cell Therapy for R/R ITP

/refractory Immune thrombocytopenia(R/R ITP).

  • 0 views
  • 19 Apr, 2022
  • 1 location